-
1
PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study
Published 2023-09-01Subjects: Get full text
Article -
2
Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
Published 2024-12-01Subjects: “…severe asthma with an eosinophilic phenotype…”
Get full text
Article